{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:47:19Z","timestamp":1787021239936,"version":"build-2736575974"},"reference-count":59,"publisher":"The Endocrine Society","issue":"10","license":[{"start":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T00:00:00Z","timestamp":1595548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,10,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Cancer survivors with GH deficiency (GHD) receive GH therapy (GHT) after 1+ year observation to ensure stable tumor status\/resolution.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Hypothesis<\/jats:title>\n                    <jats:p>Radiation therapy (RT) to brain, spine, or extremities alters growth response to GHT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim<\/jats:title>\n                    <jats:p>Identify differences in growth response to GHT according to type\/location of RT.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The Pfizer International Growth Database was searched for cancer survivors on GHT for \u22655 years. Patient data, grouped by tumor type, were analyzed for therapy (surgery, chemotherapy, RT of the focal central nervous system, cranial, craniospinal, or total body irradiation [TBI] as part of bone marrow transplantation), sex, peak stimulated GH, age at GHT start, and duration from RT to GHT start. Kruskal-Wallis test and quantile regression modeling were performed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Of 1149 GHD survivors on GHT for \u22655 years (male 733; median age 8.4 years; GH peak 2.8 ng\/mL), 431 had craniopharyngioma (251, cranial RT), 224 medulloblastoma (craniospinal RT), 134 leukemia (72 TBI), and 360 other tumors. Median age differed by tumor group (P &amp;lt; 0.001). Five-year delta height SD score (SDS) (5-year \u2206HtSDS; median [10th-90th percentile]) was greatest for craniopharyngioma, 1.6 (0.3-3.0); for medulloblastoma, 5-year \u2206HtSDS 0.9 (0.0-1.9); for leukemia 5-year \u2206HtSDS, after TBI (0.3, 0-0.7) versus without RT (0.5, 0-0.9), direct comparison P &amp;lt; 0.001. Adverse events included 40 treatment-related, but none unexpected.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>TBI for leukemia had significant impact on growth response to GHT. Medulloblastoma survivors had intermediate GHT response, whereas craniopharyngioma cranial RT did not alter GHT response. Both craniospinal and epiphyseal irradiation negatively affect growth response to GH therapy compared with only cranial RT or no RT.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1210\/clinem\/dgaa478","type":"journal-article","created":{"date-parts":[[2020,7,24]],"date-time":"2020-07-24T13:27:34Z","timestamp":1595597254000},"page":"e3730-e3741","source":"Crossref","is-referenced-by-count":14,"title":["Response to GH Treatment After Radiation Therapy Depends on Location of Irradiation"],"prefix":"10.1210","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1328-1289","authenticated-orcid":false,"given":"Susan R","family":"Rose","sequence":"first","affiliation":[{"name":"Pediatric Endocrinology and Metabolism, Cincinnati Children\u2019s Hospital Medical Center, University of Cincinnati College of Medicine, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3106-0754","authenticated-orcid":false,"given":"Martin","family":"Carlsson","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Endocrine Care, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1523-1536","authenticated-orcid":false,"given":"Adda","family":"Grimberg","sequence":"additional","affiliation":[{"name":"Perelman School of Medicine, Univ. of Pennsylvania, Children\u2019s Hospital of Philadelphia, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferah","family":"Aydin","sequence":"additional","affiliation":[{"name":"Pfizer Health AB, Endocrine Care, Sollentuna, Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4051-6661","authenticated-orcid":false,"given":"Assunta","family":"Albanese","sequence":"additional","affiliation":[{"name":"St George\u2019s University Hospitals NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita C S","family":"Hokken-Koelega","sequence":"additional","affiliation":[{"name":"Dutch Growth Research Foundation, Rotterdam, The Netherlands"},{"name":"Erasmus University Medical Center, Sophia\u2019s Children\u2019s Hospital, Department of Pediatrics, Division of Endocrinology, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Camacho-Hubner","sequence":"additional","affiliation":[{"name":"Pfizer Inc., Endocrine Care, New York, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2020,7,24]]},"reference":[{"key":"2021122105535383400_CIT0001","author":"CureSearch Children\u2019s Oncology Group."},{"key":"2021122105535383400_CIT0002","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/978-3-319-16435-9_5","article-title":"Endocrine complications of cancer therapy","volume-title":"Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach.","author":"Rose","year":"2015","edition":"3"},{"issue":"8","key":"2021122105535383400_CIT0003","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1210\/jc.2018-01175","article-title":"Hypothalamic-pituitary and growth disorders in survivors of childhood cancer: an endocrine society clinical practice guideline","volume":"103","author":"Sklar","year":"2018","journal-title":"J Clin Endocrinol Metab."},{"issue":"6","key":"2021122105535383400_CIT0004","doi-asserted-by":"crossref","first-page":"R153","DOI":"10.1530\/EJE-13-0434","article-title":"Endocrine side-effects of anti-cancer drugs: mAbs and pituitary dysfunction: clinical evidence and pathogenic hypotheses","volume":"169","author":"Torino","year":"2013","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2021122105535383400_CIT0005","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1677\/ERC-10-0002","article-title":"Endocrine complications in long-term survivors of childhood cancers","volume":"17","author":"Chemaitilly","year":"2010","journal-title":"Endocr Relat Cancer."},{"issue":"3","key":"2021122105535383400_CIT0006","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ijrobp.2012.07.008","article-title":"Dose-effect relationships for adverse events after cranial radiation therapy in long-term childhood cancer survivors","volume":"85","author":"van Dijk","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys."},{"issue":"2","key":"2021122105535383400_CIT0007","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000336688","article-title":"Age at menarche in childhood cancer survivors: results of a nationwide survey in Germany","volume":"77","author":"Wessel","year":"2012","journal-title":"Horm Res Paediatr."},{"issue":"2","key":"2021122105535383400_CIT0008","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1159\/000327584","article-title":"Endocrine outcome in long-term survivors of childhood brain tumors","volume":"76","author":"Shalitin","year":"2011","journal-title":"Horm Res Paediatr."},{"issue":"6","key":"2021122105535383400_CIT0009","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/pbc.20327","article-title":"ACTH deficiency in childhood cancer survivors","volume":"45","author":"Rose","year":"2005","journal-title":"Pediatr Blood Cancer."},{"issue":"7","key":"2021122105535383400_CIT0010","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/pbc.22208","article-title":"Adrenal function testing in pediatric cancer survivors","volume":"53","author":"Patterson","year":"2009","journal-title":"Pediatr Blood Cancer."},{"key":"2021122105535383400_CIT0011","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-319-16435-9","volume-title":"Survivors of Childhood and Adolescent Cancer: A Multidisciplinary Approach","author":"Schwartz","year":"2015","edition":"3"},{"issue":"1","key":"2021122105535383400_CIT0012","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12185-010-0611-z","article-title":"Late effects and quality of life of childhood cancer survivors: part 2. Impact of radiotherapy","volume":"92","author":"Ishida","year":"2010","journal-title":"Int J Hematol."},{"issue":"5","key":"2021122105535383400_CIT0013","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/S0360-3016(01)02788-2","article-title":"Radiation dose-volume effects on growth hormone secretion","volume":"52","author":"Merchant","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"2021122105535383400_CIT0014","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1530\/EJE-09-0328","article-title":"From isolated GH deficiency to multiple pituitary hormone deficiency: an evolving continuum - a KIMS analysis","volume":"161","author":"Klose","year":"2009","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122105535383400_CIT0015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2016.45","article-title":"Late endocrine effects of childhood cancer","volume":"12","author":"Rose","year":"2016","journal-title":"Nat Rev Endocrinol."},{"key":"2021122105535383400_CIT0016","first-page":"267","volume-title":"Preservation of Fertility.","author":"Tulandi","year":"2004"},{"issue":"286","key":"2021122105535383400_CIT0017","first-page":"165","article-title":"Effects of cranial irradiation on hypothalamic-pituitary function\u2014a 5-year longitudinal study in patients with nasopharyngeal carcinoma","volume":"78","author":"Lam","year":"1991","journal-title":"Q J Med."},{"issue":"9","key":"2021122105535383400_CIT0018","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1007\/s00432-011-1004-2","article-title":"Endocrine late effects after total body irradiation in patients who received hematopoietic cell transplantation during childhood: a retrospective study from a single institution","volume":"137","author":"Felicetti","year":"2011","journal-title":"J Cancer Res Clin Oncol."},{"issue":"36","key":"2021122105535383400_CIT0019","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1200\/JCO.2011.37.9453","article-title":"Growth hormone secretion after conformal radiation therapy in pediatric patients with localized brain tumors","volume":"29","author":"Merchant","year":"2011","journal-title":"J Clin Oncol."},{"issue":"21","key":"2021122105535383400_CIT0020","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1200\/JCO.2017.77.0180","article-title":"Surveillance for late effects in childhood cancer survivors","volume":"36","author":"Landier","year":"2018","journal-title":"J Clin Oncol."},{"key":"2021122105535383400_CIT0021","author":"Landier","year":"2019"},{"key":"2021122105535383400_CIT0022","first-page":"443","article-title":"Toxicity and late effects","volume-title":"Brain and Spinal Tumors of Childhood.","author":"Spoudeas","year":"2004"},{"issue":"6","key":"2021122105535383400_CIT0023","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1159\/000452150","article-title":"Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents: growth hormone deficiency, idiopathic short stature, and primary insulin-like growth factor-I deficiency","volume":"86","author":"Grimberg","year":"2016","journal-title":"Horm Res Paediatr."},{"issue":"6","key":"2021122105535383400_CIT0024","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1210\/jc.2015-1002","article-title":"Risk of neoplasia in pediatric patients receiving growth hormone therapy\u2014a report from the pediatric endocrine society drug and therapeutics committee","volume":"100","author":"Raman","year":"2015","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122105535383400_CIT0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Ross","year":"2016","journal-title":"Eur J Endocrinol."},{"issue":"6","key":"2021122105535383400_CIT0026","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021122105535383400_CIT0027","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1080\/08035250600577889","article-title":"Recurrence of brain tumours in patients treated with growth hormone: analysis of KIGS (Pfizer International Growth Database)","volume":"95","author":"Darendeliler","year":"2006","journal-title":"Acta Paediatr."},{"issue":"3","key":"2021122105535383400_CIT0028","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","article-title":"Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement","volume":"63","author":"Chung","year":"2005","journal-title":"Clin Endocrinol (Oxf)."},{"issue":"2","key":"2021122105535383400_CIT0029","first-page":"103","article-title":"Growth hormone treatment and risk of solid tumours. a statement from the drugs and therapeutics committee of the European Society for Paediatric Endocrinology (ESPE)","volume":"60","author":"Juul","year":"2003","journal-title":"Horm Res."},{"issue":"6","key":"2021122105535383400_CIT0030","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1210\/jc.2011-0179","article-title":"Evaluation and treatment of adult growth hormone deficiency: an endocrine society clinical practice guideline","volume":"96","author":"Molitch","year":"2011","journal-title":"J Clin Endocrinol Metab."},{"issue":"10","key":"2021122105535383400_CIT0031","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1056\/NEJMoa013555","article-title":"Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature","volume":"348","author":"Yanovski","year":"2003","journal-title":"N Engl J Med."},{"issue":"6","key":"2021122105535383400_CIT0032","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archpedi.1996.02170310023003","article-title":"Age at onset of puberty following high-dose central nervous system radiation therapy","volume":"150","author":"Oberfield","year":"1996","journal-title":"Arch Pediatr Adolesc Med."},{"issue":"11","key":"2021122105535383400_CIT0033","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1002\/cncr.24294","article-title":"Abnormal timing of menarche in survivors of central nervous system tumors: a report from the Childhood Cancer Survivor Study","volume":"115","author":"Armstrong","year":"2009","journal-title":"Cancer."},{"issue":"6","key":"2021122105535383400_CIT0034","first-page":"1282","article-title":"Cranial irradiation and early puberty","volume":"78","author":"Ogilvy-Stuart","year":"1994","journal-title":"J Clin Endocrinol Metab."},{"issue":"3","key":"2021122105535383400_CIT0035","first-page":"160","article-title":"Surgical correction of postradiation spinal deformity","volume":"26","author":"Chen","year":"2003","journal-title":"Chang Gung Med J."},{"issue":"10","key":"2021122105535383400_CIT0036","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/sj.bmt.1702021","article-title":"Growth in children with poor-risk neuroblastoma after regimens with or without total body irradiation in preparation for autologous bone marrow transplantation","volume":"24","author":"Hovi","year":"1999","journal-title":"Bone Marrow Transplant."},{"issue":"3","key":"2021122105535383400_CIT0037","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.radonc.2015.02.016","article-title":"The effects of radiation therapy on height and spine MRI characteristics in children with neuroblastoma","volume":"114","author":"Yu","year":"2015","journal-title":"Radiother Oncol."},{"issue":"1","key":"2021122105535383400_CIT0038","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1148\/114.1.155","article-title":"The effects of radiation therapy on bone growth","volume":"114","author":"Probert","year":"1975","journal-title":"Radiology."},{"issue":"6","key":"2021122105535383400_CIT0039","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/adc.53.6.491","article-title":"Growth impairment in children treated for brain tumours","volume":"53","author":"Shalet","year":"1978","journal-title":"Arch Dis Child."},{"issue":"5","key":"2021122105535383400_CIT0040","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1182\/blood.V68.5.1129.1129","article-title":"Growth and development following marrow transplantation for leukemia","volume":"68","author":"Sanders","year":"1986","journal-title":"Blood."},{"issue":"2","key":"2021122105535383400_CIT0041","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1203\/01.pdr.0000199550.71887.ba","article-title":"Patterns of growth and body proportions after total-body irradiation and hematopoietic stem cell transplantation during childhood","volume":"59","author":"Bakker","year":"2006","journal-title":"Pediatr Res."},{"issue":"2","key":"2021122105535383400_CIT0042","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819","article-title":"Growth in children after bone marrow transplantation for acute leukemia","volume":"86","author":"Huma","year":"1995","journal-title":"Blood."},{"issue":"2","key":"2021122105535383400_CIT0043","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1210\/jcem-68-2-346","article-title":"A prospective study of the development of growth hormone deficiency in children given cranial irradiation, and its relation to statural growth","volume":"68","author":"Brauner","year":"1989","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122105535383400_CIT0044","first-page":"19","article-title":"[The evaluation of the influence of growth hormone therapy on growing process and metabolic functions in patients after treatment of craniopharyngioma.]","volume":"16","author":"Oko\u0144ska","year":"2010","journal-title":"Pediatr Endocrinol Diabetes Metab."},{"issue":"1","key":"2021122105535383400_CIT0045","doi-asserted-by":"crossref","first-page":"88","DOI":"10.2307\/146316","article-title":"Recent advances in quantile regression models: a practical guideline for empirical research","volume":"33","author":"Buchinsky","year":"1998","journal-title":"J Hum Resour."},{"issue":"6","key":"2021122105535383400_CIT0046","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/adc.66.6.689","article-title":"Growth hormone treatment of growth failure secondary to total body irradiation and bone marrow transplantation","volume":"66","author":"Papadimitriou","year":"1991","journal-title":"Arch Dis Child."},{"issue":"12","key":"2021122105535383400_CIT0047","doi-asserted-by":"crossref","first-page":"6100","DOI":"10.1210\/jc.2004-1515","article-title":"Growth hormone therapy in children after cranial\/craniospinal radiation therapy: sexually dimorphic outcomes","volume":"89","author":"Lerner","year":"2004","journal-title":"J Clin Endocrinol Metab."},{"issue":"2","key":"2021122105535383400_CIT0048","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/adc.73.2.141","article-title":"Growth and puberty after growth hormone treatment after irradiation for brain tumours","volume":"73","author":"Ogilvy-Stuart","year":"1995","journal-title":"Arch Dis Child."},{"issue":"4","key":"2021122105535383400_CIT0049","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/j.1651-2227.1988.tb10705.x","article-title":"Children with craniopharyngioma. Early growth failure and rapid postoperative weight gain","volume":"77","author":"Sorva","year":"1988","journal-title":"Acta Paediatr Scand."},{"issue":"6","key":"2021122105535383400_CIT0050","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-15-0709","article-title":"History before diagnosis in childhood craniopharyngioma: associations with initial presentation and long-term prognosis","volume":"173","author":"Hoffmann","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"15","key":"2021122105535383400_CIT0051","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.1200\/JCO.2003.03.068","article-title":"Height and weight in children treated for acute lymphoblastic leukemia: relationship to CNS treatment","volume":"21","author":"Dalton","year":"2003","journal-title":"J Clin Oncol."},{"key":"2021122105535383400_CIT0052","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/1471-2431-14-236","article-title":"Final height and body mass index in adult survivors of childhood acute lymphoblastic leukemia treated without cranial radiotherapy: a retrospective longitudinal multicenter Italian study","volume":"14","author":"Bruzzi","year":"2014","journal-title":"BMC Pediatr."},{"issue":"6","key":"2021122105535383400_CIT0053","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/BF00442470","article-title":"Growth response to growth hormone therapy following cranial irradiation","volume":"147","author":"Clayton","year":"1988","journal-title":"Eur J Pediatr."},{"issue":"5","key":"2021122105535383400_CIT0054","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/j.1651-2227.1990.tb11509.x","article-title":"Response to growth hormone treatment and final height after cranial or craniospinal irradiation","volume":"79","author":"Sulmont","year":"1990","journal-title":"Acta Paediatr Scand."},{"issue":"1","key":"2021122105535383400_CIT0055","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1515\/JPEM.1997.10.1.41","article-title":"Growth hormone treatment in irradiated children with brain tumors","volume":"10","author":"Corrias","year":"1997","journal-title":"J Pediatr Endocrinol Metab."},{"issue":"10","key":"2021122105535383400_CIT0056","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/j.1651-2227.1990.tb11357.x","article-title":"Growth and growth hormone secretion in children following treatment of brain tumours with radiotherapy","volume":"79","author":"Darendeliler","year":"1990","journal-title":"Acta Paediatr Scand."},{"issue":"3","key":"2021122105535383400_CIT0057","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bbmt.2011.12.519","article-title":"Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation","volume":"18","author":"Majhail","year":"2012","journal-title":"Biol Blood Marrow Transplant."},{"issue":"11","key":"2021122105535383400_CIT0058","first-page":"3990","article-title":"Consensus guidelines for the diagnosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: summary statement of the GH Research Society","volume":"85","author":"Growth Hormone Research Society.","year":"2000","journal-title":"J Clin Endocrinol Metab."},{"issue":"1","key":"2021122105535383400_CIT0059","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2014.08.018","article-title":"Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours","volume":"113","author":"Appelman-Dijkstra","year":"2014","journal-title":"Radiother Oncol."}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/advance-article-pdf\/doi\/10.1210\/clinem\/dgaa478\/33565421\/dgaa478.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/e3730\/41828038\/dgaa478.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jcem\/article-pdf\/105\/10\/e3730\/41828038\/dgaa478.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,21]],"date-time":"2021-12-21T00:56:05Z","timestamp":1640048165000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/105\/10\/e3730\/5876029"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,24]]},"references-count":59,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2020,7,24]]},"published-print":{"date-parts":[[2020,10,1]]}},"URL":"https:\/\/doi.org\/10.1210\/clinem\/dgaa478","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,7,24]]}}}